Autoimmunity in chronic obstructive pulmonary disease: Clinical and experimental evidence

Expert Review of Clinical Immunology

Volumn 8, Issue 3, 2012, Pages 285-292

  Kheradmand, Farrah ^a,b,c   Shan, Ming ^a   Xu, Chuang ^a   Corry, David B ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Michael E DeBakey VA   (United States)

^c One Baylor Plaza M915B ^*  (United States)

Author keywords

adaptive immunity; antigen presenting cells; cytokines; Th1; Th17

Indexed keywords

ALPHA 1 ANTITRYPSIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; EMPHYSEMA; ENZYME ACTIVITY; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; NONHUMAN; RESPIRATORY TRACT INFECTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; THORAX RADIOGRAPHY;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-17; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING; TH1 CELLS; TH17 CELLS;

EID: 84858433903     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.7     Document Type: Review

References (63)

1. Brown DW, Croft JB, Greenlund KJ, WH Giles. Deaths from chronic obstructive pulmonary disease - United States, 2000-2005. J. Am. Med. Assoc. 301(13), 1331-1333 (2009).
2. Takubo Y, Guerassimov A, Ghezzo H et al. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: Parallels with human disease. Am. J. Respir. Crit. Care Med. 166(12 Pt 1), 1596-1603 (2002).
3. Newell JD Jr. CT of emphysema. Radiol. Clin. North Am. 40(1), 31-42, (2002).
4. Spaggiari E, Zompatori M, Verduri A et al. Early smoking-induced lung lesions in asymptomatic subjects. Correlations between high resolution dynamic CT and pulmonary function testing. Radiol. Med. 109(1-2), 27-39 (2005).
5. Hesselbacher SE, Ross R, Schabath MB et al. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int. J. Environ. Res. Public Health 8(5), 1324-1340 (2011).
6. Spitz MR, Hong WK, Amos CI et al. A risk model for prediction of lung cancer. J. Natl Cancer Inst. 99(9), 715-726 (2007).
7. Wilson DO, Weissfeld JL, Balkan A et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med. 178(7), 738-744 (2008).
8. Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu. Rev. Immunol. 27, 363-391 (2009).
9. Laurell CB, Eriksson S. The serum alpha-l-antitrypsin in families with hypo-alpha-l-antitrypsinemia. Clin. Chim. Acta. 11, 395-398 (1965).
10. Castaldi PJ, Cho MH, Cohn M et al. The COPD genetic association compendium: A comprehensive online database of COPD genetic associations. Hum. Mol. Genet. 19(3), 526-534 (2010).
11. Greene CM, Hassan T, Molloy K, McElvaney NG. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and alpha-1 anti-trypsin deficiency. Expert Rev. Respir. Med. 5(3), 395-411 (2011).
12. Kong X, Cho MH, Anderson W et al. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am. J. Respir. Crit. Care Med. 183(1), 43-49 (2011).
13. Regan EA, Hokanson JE, Murphy JR et al. Genetic epidemiology of COPD (COPDGene) study design. J. Chron. Obstruct. Pulmon. Dis. 7(1), 32-43 (2010).
14. Pillai SG, Ge D, Zhu G et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet. 5(3), e1000421 (2009).
15. Thorgeirsson TE, Geller F, Sulem P et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187), 638-642 (2008).
16. Thorgeirsson TE, Gudbjartsson DF, Surakka I et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42(5), 448-453 (2010).
17. Kaplan PD, Kuhn C, Pierce JA. The induction of emphysema with elastase. I. The evolution of the lesion and the influence of serum. J. Lab. Clin. Med. 82(3), 349-356 (1973).
18. Shapiro SD. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med. 150(6 Pt 2), S160-S164 (1994).
19. Senior RM, Connolly NL, Cury JD, Welgus HG, Campbell EJ. Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139(5), 1251-1256 (1989).
20. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu. Rev. Pathol. 4, 435-459 (2009).
21. Churg A, Zay K, Shay S et al. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am. J. Respir. Cell Mol. Biol. 27(3), 368-374 (2002).
22. Lee SH, Goswami S, Grudo A et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 13(5), 567-569 (2007).
23. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 360(23), 2445-2454 (2009).
24. Senior RM, Griffin GL, Mecham RP et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J. Cell Biol. 99(3), 870-874 (1984).
25. van Houwelingen AH, Weathington NM, Verweij V et al. Induction of lung emphysema is prevented by l-arginine-threonine-arginine. FASEB Journal. 22(9), 3403-3408 (2008).
26. Weathington NM, van Houwelingen AH, Noerager BD et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12(3), 317-323 (2006).
27. Saetta M, Baraldo S, Corbino L et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160(2), 711-717 (1999).
28. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of lung health study participants after 11 years. Am. J. Respir. Crit. Care Med. 166(5), 675-679 (2002).
29. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am. J. Respir. Crit. Care Med. 160(5 Pt 2), S21-S25 (1999).
30. 4+ T cell lineup. Nature Immunology. 11(1), 36-40 (2010).
31. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
32. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162(1), 1-11 (2010).
33. Shan M, Yuan X, Song L et al. Cigarette smoke induction of osteopontin (SPP1) mediates Th17 inflammation in human and experimental emphysema. Sci. Transl. Med. (4), 117 (2012).
34. Hanauer SB, Cohen RD, Becker RV 3rd, Larson LR, Vreeland MG. Advances in the management of Crohn's disease: Economic and clinical potential of infliximab. Clin. Ther. 20(5), 1009-1028 (1998).
35. D'Hulst AI, Maes T, Bracke KR et al. Cigarette smoke-induced pulmonary emphysema in SCID-mice. Is the acquired immune system required? Respiratory Research. 6, 147 (2005).
36. Guerassimov A, Hoshino Y, Takubo Y et al. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170(9), 974-980 (2004).
37. Grumelli S, Corry DB, Song LZ et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 1(1), e8 (2004).
38. Panina-Bordignon P, Papi A, Mariani M et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J. Clin. Invest. 107(11), 1357-1364 (2001).
39. Shan M., Cheng H.F., Song L.Z., Roberts L., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H.O., Storness-Bliss C., Ramchandani M., Lee S.H., Corry D.B., Kheradmand F. Lung myeloid dendritic cells coordinately induce Th1 and Th17 responses in human emphysema. Science translational medicine, 1(4), 132-140 (2009).
40. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24(6), 677-688 (2006).
41. Feghali-Bostwick C, Gadgil A, Otterbein L et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177(2),156-163 (2008).
42. Nunez B, Sauleda J, Anto JM et al. Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1183(8), 1025-1031 (2011).
43. Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am. J. Respir. Crit. Care Med. 181(1), 31-35 (2009).
44. Cottin V, Fabien N, Khouatra C, Moreira A, Cordier JF. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur. Respir. J. 33(1), 219-221 (2009).
45. Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J. Immunol. Methods 216(1-2), 117-137 (1998).
46. Zelenay S, Moraes Fontes MF, Fesel C, Demengeot J, Coutinho A. Physiopathology of natural auto-antibodies: The case for regulation. J. Autoimmun. 29(4), 229-235 (2007).
47. da Mota LM, dos Santos Neto LL, de Carvalho JF. Autoantibodies and other serological markers in rheumatoid arthritis: Predictors of disease activity? Clin. Rheumatol. 28(10), 1127-1134 (2009).
48. Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and future. Autoimmunity 43(1), 84-97 (2010).
49. GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol. 1(6), 442-450 (2008).
50. Mahnke K, Guo M, Lee S et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151(3), 673-684 (2000).
51. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11(2), 119-130 (2011).
52. Tsoumakidou M, Zhu J, Wang Z et al. Immunohistochemical detection of dendritic cells in human lung tissue. Histopathology 51(4), 565-568 (2007).
53. Demedts IK, Bracke KR, Van Pottelberge G et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175(10), 998-1005 (2007).
54. Singh M, Lee S-H, Porter P et al. Human Rhinovirus proteinase 2A induces Th1 and Th2 immunity in COPD. J. Allergy Clin. Immunol. 125, 1369-1378 (2010).
55. Bandi V, Jakubowycz M, Kinyon C et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol. Med. Microbiol. 37(1), 69-75 (2003).
56. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164(9), 1618-1623 (2001).
57. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161(5), 1608-1613 (2000).
58. Wilkinson TMA, Donaldson GC, Johnston SL, Openshaw PJM, Wedzicha JA. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173(8), 871-876 (2006).
59. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11(4), 443-451 (1999).
60. Doz E, Noulin N, Boichot E et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J. Immunol. 180(2), 1169-1178 (2008).
61. Knobloch J, Schild K, Jungck D et al. The T-helper cell type 1 immune response to Gram-negative bacterial infections is impaired in COPD. Am. J. Respir. Crit. Care Med. 183(2), 204-214 (2011).
62. Shapiro SD, Campbell EJ, Welgus HG, Senior RM. Elastin degradation by mononuclear phagocytes. Ann. NY Acad. Sci. 624, 69-80 (1991).
63. Shapiro SD. End-stage chronic obstructive pulmonary disease: The cigarette is burned out but inflammation rages on. Am. J. Respir. Crit. Care Med. 164(3), 339-340 (2001).